Sun’s research found that, in the diabetic nephropathy (DN) model, by activating the JAK/STAT3 signaling pathway, CXCL6 might enhance fibrosis-related variables to hasten the development of DN renal interstitial fibrosis (60). Here, CXCL6 is linked to liver dysplastic nodule.